Auspex Pharmaceuticals Inc ., which is developing therapies for orphan diseases, has appointed four life-science industry veterans to its executive team as it advances its lead product candidate through late-stage trials.<br /><br />The La Jolla, Calif., company has named Executive Chairman Pratik Shah as president and chief executive. He will continue as a director and partner with Thomas McNerney & Partners , the company's largest shareholder.